Tuesday, January 31, 2012

Polio consultant awarded prestigious Gates Vaccine Innovation Award

Wednesday, January 25, 2012
Polio consultant awarded prestigious Gates Vaccine Innovation Award
The Bill and Melinda Gates Foundation has awarded its prestigious Vaccine Innovation Award to polio consultant Dr Asm Amjad Hossain

<P align=justify><EM>The Bill and Melinda Gates Foundation has awarded its prestigious Vaccine Innovation Award to polio consultant Dr Asm Amjad Hossain</EM></P>
Melinda Gates, co-chair of the Bill and Melinda Gates Foundation, meets with Dr Asm Amjad Hossain, the recipient of the first Gates Vaccine Innovation Award
Bill and Melinda Gates Foundation
Dr Hossain, originally from Bangladesh and currently based in Nigeria supporting the country's polio eradication efforts there, received the Award from among 117 nominations encompassing a range of innovative solutions to increase vaccination coverage.

The Award is in direct recognition of Dr Hossain's innovative work in raising immunization coverage rates in key districts of Bangladesh, by institutionalising processees for registering pregnant women with expected delivery dates, annual schedules for vaccine sessions, and key active community outreach strategies. "(These innovations) show how looking at old problems in new ways can make a profound difference," said Mr Bill Gates, co-chair of the Bill and Melinda Gates Foundation. "Improvements like these are spreading to other locations because of the commitment and creativity of Dr Hossain and many others like him."

The Award was established by the Bill and Melinda Gates Foundation to recognize and celebrate revolutionary ways in which children in the poorest parts of the world are immunized. The Award winner is recognized with US$250,000 and personally acknowledged by Gates Foundation leadership.
source:
http://www.polioeradication.org/tabid/461/iid/191/Default.aspx



Sunday, January 8, 2012

VIRULENT STRAIN IN THE AIR : TDR TB


Publication: The Times Of India Delhi; Date: Jan 8, 2012; Section: Times Nation; Page: 10


 New, deadlier form of TB hits India 12 Totally Drug-Resistant Cases Of Killer Disease Isolated At Mumbai Hospital
Malathy Iyer TNN



Mumbai: Tuberculosis, which kills around 1,000 people every day in India, has acquired a deadlier edge. A new entity — ominously called Totally Drug-Resistant TB (TDRTB) — has been isolated in the fluid samples of 12 TB patients in the past three months alone at Hinduja Hospital at Mahim in Mumbai. The hospital’s laboratory has been certified by the World Health Organization (WHO) to test TB patients for drug resistance.

    While Iran first reported TDR-TB cases three years ago, India seems to be only the second country to report this deadly form of the disease. TDR-TB is the result of the latest mutation of the bacilli after Multi-Drug-Resistant TB (MDR-TB) and Extremely Drug-Resistant TB (XDR-TB) were diagnosed earlier.

    Even more worryingly for Mumbai, 10 of the 12 TDR-TB cases are from the city, while the other two are patients from Ratnagiri and Uttar Pradesh. One of the 12 patients has since died. India sees around 3-4 lakh deaths for all forms of TB each year, while the world saw 1.7 million deaths in 2009.

    As the full form of TDR-TB suggests, none of the known TB combination drugs work on the patient. All 12 showed resistance to 12 drugs. “The TB bacilli have obviously mutated. The emergence of TDR-TB has grave implications for public health,’’ said Hinduja Hospital’s Dr Zarir Udwadia, whose observations have been published in the latest issue of the US-based Clinical Infectious Diseases (CID) peer review journal. His team started isolating TDR-TB cases among patients with pulmonary TB in October last year.

    Dr Amita Athawale, who heads KEM Hospital’s chest department, said TDR-TB was a reality in India. “The cases we clinically isolate are just the tip of the iceberg,’’ she said. TB is one of the biggest killers in India, along with heart attack.

    Among tuberculosis patients, drug resistance develops mainly because patients fail to complete the 6-9 month first treatment phase. “They feel better within a couple of months of taking the drugs and so they stop taking them. However, the TB germs in the body are not completely vanquished and they again multiply,’’ said a senior BMC public health official.

Tuberculosis is one of the most fatal diseases in Mumbai, accounting for nearly 15% (8,953) of the deaths in 2010

• Left untreated, each person with active TB can infect 10 to 15 people a year


• TB is a contagious disease. Like the common cold, it spreads through the air


• Patients resistant to all first-line and second-line drugs are classified as having Totally Drug-Resistant TB (TDR-TB)

An estimated 1.7 million people died from TB worldwide in 2009


• About 3 lakh to 4 lakh die of TB each year in India


• It is believed that more than half the city’s TB patients seek treatment in the private sector


Tuesday, January 3, 2012

clinical pearls: low molecular weight heparin/cushing's syndrome